"Volume 2022 (2022): Issue 053 (Nov 2022): Twelfth Periodic Monitoring Report On The Status Of Management Implementation Plans In Response To Board-Endorsed IEO Recommendations" published on 30 Nov by International Monetary Fund.

1 Department of Genetics and Animal Breeding, West Pomeranian University of Technology in Szczecin, Doktora Judyma 6, 71-466 Szczecin, Poland 2 Department of Animal Genetics and Animal Breeding, National Research Institute of Animal Production, Krakowska 1, 32-083 Balice/Kraków, Poland 3 Department of Genetics, Wrocław University of Environmental and Life Sciences, Kożuchowska 7, 51-631 Wrocław...

We present observations of the 9.8 s X-ray pulsar XTEJ1859+083 made with the ASM and PCA on board RXTE, and the WFC on board BeppoSAX. The ASM data cover a 12 year time interval and show that an extended outburst occurred between approximately MJD 50,250 and 50,460 (1996 June 16 to 1997 January 12). The ASM data excluding this outburst interval suggest a possible modulation with a period of 60....

A total of 316 toxigenic Clostridium difficile clinical isolates of known PCR ribotypes from patients in North America were screened for resistance to clindamycin, metronidazole, moxifloxacin, and rifampin. Clindamycin resistance was observed among 16 different ribotypes, with ribotypes 017, 053, and 078 showing the highest proportions of resistance. All isolates were susceptible to metronidazo...

Marc Miravitlles*,1, Kai-Michael Beeh2 & Pablo Altman3 Department of Pneumology, Hospital Universitari Vall d’Hebron, Ciber de Enfermedades Respiratorias (Ciberes), P. Vall d’Hebron 119–129, 08035, Barcelona, Spain Insaf Institut für Atemwegsforschung GmbH, Biebricher Allee 34, D-65187 Wiesbaden, Germany Novartis Pharmaceuticals Corporation, 1 Health Plz, East Hanover, NJ 07936, USA *Author for...

접수 : 2007년 12월 4일, 승인 : 2008년 1월 9일 이 연구는 2002년도 대구가톨릭대학교 의과학연구소 연구비의 지원으로 이루어졌음 책임저자 : 김우택, 대구가톨릭대학병원 소아과청소년과 Correspondence : Woo Taek Kim, M.D. Tel : 053)650-4250 Fax : 053)622-4240 E-mail : [email protected] xia at birth is estimates to be 0.2-0.4% in full-term newborn infants and approaches 60% in preterm infants. About 20-50% of infants suffering from H-I encephalopathy expire during the ...